While there is a clear interaction of antigen‐dependent and BCR‐autonomous signaling with the integrin and back, the molecular players are not well defined yet and the bypass mechanisms of BTK in CD49d‐positive CLL patients remain to be resolved. The gene discussed is ITGA4; the disease is B-cell chronic lymphocytic leukemia.